09:51 AM EDT, 04/04/2025 (MT Newswires) -- NurExone Biologic ( NRXBF ) on Friday said it has raised $2.3 million in a private placement of units.
The company issued 3.5 million units at $0.65 each. Each unit includes one share and one 36-month warrant that can buy a common share at $0.85.
Proceeds will be used to establish a U.S. production facility and an uplisting to a major U.S. exchange, subject to requisite regulatory approval.
NurExone was last seen unchanged at $0.66, on the TSX Venture Exchange.
Price: 0.66, Change: -0.01, Percent Change: -1.49